ODDB.org: Open Drug Database

Sanofi-Aventis (Suisse) SA - Aprovel 300, comprimés pelliculés

Swissmedic Registration	54250	Sequence	03
Product name	Aprovel 300	Description	comprimés pelliculés
ATC-Classification	C09CA04	ATC-Description	Irbesartan
Introduction of Sequence	21.12.1999

Composition

Comprimé pelliculé: irbesartanum 300 mg, lactosum monohydricum 102 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 2.184 mg, hypromellosum, silica colloidalis hydrica, magnesii stearas, pellicule: lactosum monohydricum 7.2 mg, hypromellosum, macrogolum 3000, E 171, cera carnauba, pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose	additional_information
Irbesartan	300 mg	Comprimé pelliculé

BAG: Active Agent	Dose
Irbesartan	300 mg

Inactive agents	Dose	additional_information
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Cera Carnauba
E 171		color.
Hypromellosum
Lactose Monohydrate	7.2 mg	pellicule
Macrogol	3000
Magnesii Stearas
Pro Compresso Obducto
Silica Colloidalis Hydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
134	28 Tablet(s)	18.28	36.20	B	SL	No
142	98 Tablet(s)	63.11	84.70	B	SL	No

2025	©ywesee GmbH